109 related articles for article (PubMed ID: 21269563)
1. The association between the copy-number variations of ZMAT4 and hematological malignancy.
Wan J; Gao Y; Zhao X; Wu Q; Fu X; Shao Y; Yang H; Guan M; Yu B; Zhang W
Hematology; 2011 Jan; 16(1):20-3. PubMed ID: 21269563
[TBL] [Abstract][Full Text] [Related]
2. Analysis of copy number variations of BS69 in multiple types of hematological malignancies.
Yang H; Zhang C; Zhao X; Wu Q; Fu X; Yu B; Shao Y; Guan M; Zhang W; Wan J; Huang X
Ann Hematol; 2010 Oct; 89(10):959-64. PubMed ID: 20425112
[TBL] [Abstract][Full Text] [Related]
3. Copy number variations of EphA3 are associated with multiple types of hematologic malignancies.
Guan M; Liu L; Zhao X; Wu Q; Yu B; Shao Y; Yang H; Fu X; Wan J; Zhang W
Clin Lymphoma Myeloma Leuk; 2011 Feb; 11(1):50-3. PubMed ID: 21454190
[TBL] [Abstract][Full Text] [Related]
4. Examination of copy number variations of CHST9 in multiple types of hematologic malignancies.
Zhao X; Wu Q; Fu X; Yu B; Shao Y; Yang H; Guan M; Huang X; Zhang W; Wan J
Cancer Genet Cytogenet; 2010 Dec; 203(2):176-9. PubMed ID: 21156230
[TBL] [Abstract][Full Text] [Related]
5. Investigation of copy-number variations of C8orf4 in hematological malignancies.
Zhang J; Gao Y; Zhao X; Guan M; Zhang W; Wan J; Yu B
Med Oncol; 2011 Dec; 28 Suppl 1():S647-52. PubMed ID: 20878554
[TBL] [Abstract][Full Text] [Related]
6. Expression patterns of costimulatory molecules on cells derived from human hematological malignancies.
Zheng Z; Takahashi M; Aoki S; Toba K; Liu A; Osman Y; Takahashi H; Tsukada N; Suzuki N; Nikkuni K; Furukawa T; Koike T; Aizawa Y
J Exp Clin Cancer Res; 1998 Sep; 17(3):251-8. PubMed ID: 9894758
[TBL] [Abstract][Full Text] [Related]
7. Integrative oncogenomic analysis of microarray data in hematologic malignancies.
Martínez-Climent JA; Fontan L; Fresquet V; Robles E; Ortiz M; Rubio A
Methods Mol Biol; 2010; 576():231-77. PubMed ID: 19882266
[TBL] [Abstract][Full Text] [Related]
8. Hematological malignancies: role of miRNAs and their in silico aspects.
Omer A; Yadav NK; Singh P; Singh RK
Expert Rev Anticancer Ther; 2013 Sep; 13(9):1121-33. PubMed ID: 24053209
[TBL] [Abstract][Full Text] [Related]
9. Association of heparanase gene (HPSE) single nucleotide polymorphisms with hematological malignancies.
Ostrovsky O; Korostishevsky M; Levite I; Leiba M; Galski H; Vlodavsky I; Nagler A
Leukemia; 2007 Nov; 21(11):2296-303. PubMed ID: 17611567
[TBL] [Abstract][Full Text] [Related]
10. Expression and functional significance of osteocalcin splicing in disease progression of hematological malignancies.
Wihlidal P; Varga F; Pfeilstöcker M; Karlic H
Leuk Res; 2006 Oct; 30(10):1241-8. PubMed ID: 16387359
[TBL] [Abstract][Full Text] [Related]
11. Loss of expression of the human MSH3 gene in hematological malignancies.
Inokuchi K; Ikejima M; Watanabe A; Nakajima E; Orimo H; Nomura T; Shimada T
Biochem Biophys Res Commun; 1995 Sep; 214(1):171-9. PubMed ID: 7669036
[TBL] [Abstract][Full Text] [Related]
12. [Review of relationship between tumor necrosis factor genetic polymorphism and hematological malignancies].
Zhao HY; Chen YX
Ai Zheng; 2003 Feb; 22(2):216-20. PubMed ID: 12600304
[TBL] [Abstract][Full Text] [Related]
13. The Janus Kinase 2 (JAK2) V617F mutation in hematological malignancies in México.
Ruiz-Argüelles GJ; Garcés-Eisele J; Reyes-Núñez V; Ruiz-Delgado GJ; Navarro-Vázquez M; González-Carrillo ML
Rev Invest Clin; 2006; 58(5):458-61. PubMed ID: 17408106
[TBL] [Abstract][Full Text] [Related]
14. Low-penetrance susceptibility to hematological malignancy.
Houlston RS
Curr Opin Genet Dev; 2010 Jun; 20(3):245-50. PubMed ID: 20381336
[TBL] [Abstract][Full Text] [Related]
15. Retrospective evaluation of the clinical and laboratory data from 300 patients of various hematological malignancies with chromosome 3 abnormalities.
Liu D; Zhang Y; Chen S; Pan J; He X; Liang J; Chen Z
Cancer Genet; 2015 Jun; 208(6):333-40. PubMed ID: 26032184
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic inactivation of the miR-34a in hematological malignancies.
Chim CS; Wong KY; Qi Y; Loong F; Lam WL; Wong LG; Jin DY; Costello JF; Liang R
Carcinogenesis; 2010 Apr; 31(4):745-50. PubMed ID: 20118199
[TBL] [Abstract][Full Text] [Related]
17. Somatic mutations in the HLA genes of patients with hematological malignancy.
Smith AG; Fan W; Regen L; Warnock S; Sprague M; Williams R; Nisperos B; Zhao LP; Loken MR; Hansen JA; Pereira S
Tissue Antigens; 2012 May; 79(5):359-66. PubMed ID: 22489945
[TBL] [Abstract][Full Text] [Related]
18. High-resolution copy number array in the molecular cytogenetic diagnostics of pediatric malignant hematological disorders.
Wikhager C; Ögärd I; Martinsson T; Abrahamsson J; Palmqvist L; Sjögren H
Oncol Rep; 2012 May; 27(5):1429-34. PubMed ID: 22344473
[TBL] [Abstract][Full Text] [Related]
19. [Genetics of hereditary hematological malignancies].
Takagi M
Rinsho Ketsueki; 2015 Oct; 56(10):1969-77. PubMed ID: 26458435
[TBL] [Abstract][Full Text] [Related]
20. Aberrant alternative splicing of human zinc finger gene ZNF268 in human hematological malignancy.
Zhao Z; Wang D; Zhu C; Shao H; Sun C; Qiu H; Xue L; Xu J; Guo M; Li W
Oncol Rep; 2008 Nov; 20(5):1243-8. PubMed ID: 18949428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
